Companies: 10,795·Total market cap: $144.5T
MorphoSys AG

MorphoSys AG

MPSYFOTCHealthcare
$73.27
+$1.51(+2.10%)
Market Cap$2.8B
P/E Ratio
52W High$73.27
52W Low$25.56
Overview

MorphoSys AG(MPSYF)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

mpsyf · 股价预测 · 7 位分析师(近3月)· FMP · 更新于 2025年11月18日

分析师评级与共识

基于过去 3 个月内 7 位华尔街分析师

SellBuy

Buy

7 位分析师

共识

评级分布

Strong Buy
0
Buy
4
Hold
3
Sell
0
Strong Sell
0
合计: 7 · 买入占比: 57.1%

12 个月目标价

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $73.27

MorphoSys AG(MPSYF)的分析师共识为 Buy,基于过去 3 个月内 7 位华尔街分析师的评级。MPSYF 的 12 个月平均目标价为 $0.00,相对当前价 $73.27 代表 +0.0% 的潜在上行空间。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-09$72.830.60%

1-day model range: $72.83–$72.83. Peak: $72.83 (-0.60%).

长期股价预测

⚠️ 在满 252 个交易日历史(IPO/上市时间较短)前不展示长期预测;短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

NEUTRAL

Based on 14 technical indicators

50%43%7%
7Buy
6Neutral
1Sell
RSI (14)100.0Overbought
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · MPSYF · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$73.27NEUTRAL
MA 10$73.27NEUTRAL
MA 20$73.27NEUTRAL
MA 50$73.27NEUTRAL
MA 100$72.98BUY
MA 200$0.00NEUTRAL
Current $MPSYF · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$73.27BUY
EMA 10$73.27BUY
EMA 20$73.27BUY
EMA 50$73.15BUY
EMA 100$72.74BUY
EMA 200$0.00NEUTRAL
Current $MPSYF · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
Morgan Stanley2023-10-12
Upgrade ↑
UnderweightOverweight
Goldman Sachs2023-09-14
Upgrade ↑
SellNeutral
JMP Securities2023-06-21
Maintains
Market OutperformMarket Outperform
JP Morgan2023-06-15
Upgrade ↑
UnderweightOverweight
JP Morgan2023-01-02
Downgrade ↓
NeutralUnderweight
JMP Securities2022-11-17
Maintains
Market OutperformMarket Outperform
Morgan Stanley2022-01-13
Downgrade ↓
OverweightEqual Weight
Deutsche Bank2021-08-05
Downgrade ↓
BuyHold
JP Morgan2021-06-10
Downgrade ↓
OverweightNeutral
Bryan Garnier2021-06-02
Downgrade ↓
BuyNeutral

Wall Street analysts have recently issued updated ratings on MorphoSys AG (MPSYF) stock. Of the recent 14 rating actions, 5 were upgrades and 6 were downgrades. 7 analysts currently cover MPSYF.

分析师推荐趋势

Buy ratings01↑ +1
Hold ratings101
Sell ratings00

MPSYF analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$303M

↓ 34.5% YoY

Revenue Next Year

$385M

↑ 27.3% YoY

EPS This Year

$-6.15

EPS Next Year

$-3.55

↓ 42.3% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast MPSYF EPS of $-6.15 for the current fiscal year, based on estimates from 1 analysts. The MPSYF revenue forecast is $303M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

MPSYF 股价预测由两类独立数据源支撑:来自 7 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。MPSYF 的共识目标价为 $0.00(+0.0% 上行空间),分析师共识为 Buy。

MPSYF 的短期预测(明日)为 $72.83(-0.60%)。

MorphoSys AG 在 OTC 上市,代码 MPSYF。MPSYF 在 2027 年的整体展望偏积极,在覆盖分析师中约 57% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

MPSYF 预测 · 8 个问题

根据 7 位华尔街分析师,MPSYF 的 12 个月平均目标价为 $0.00,最高 $0.00、最低 $0.00。若有图表,中位目标价可在上方查看。相对当前价 $73.27,隐含约 +0.0% 的上行空间。

MPSYF 目标价MPSYF 分析师目标价MPSYF 12个月目标价目标价 MPSYF

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.